14/120
0.6 / 5 stars
All 120 Win/Lose results shown below
XBIT Roast Me summary
XBiotech Inc. (XBIT). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseXBIT / S&P -2.13% / 15.20% |
LoseXBIT / S&P XBIT unavailable / 15.00% |
LoseXBIT / S&P XBIT unavailable / 50.40% |
| 2026-Q11/3 |
WinXBIT / S&P -1.67% / -4.33% |
LoseXBIT / S&P XBIT unavailable / 11.30% |
LoseXBIT / S&P XBIT unavailable / 27.70% |
| 2025-Q40/3 |
LoseXBIT / S&P -10.15% / 2.65% |
LoseXBIT / S&P XBIT unavailable / 9.00% |
LoseXBIT / S&P XBIT unavailable / 13.40% |
| 2025-Q30/3 |
LoseXBIT / S&P -10.44% / 8.12% |
LoseXBIT / S&P XBIT unavailable / 4.61% |
LoseXBIT / S&P XBIT unavailable / 13.45% |
| 2025-Q20/3 |
LoseXBIT / S&P -8.33% / 10.94% |
LoseXBIT / S&P XBIT unavailable / 4.83% |
LoseXBIT / S&P XBIT unavailable / 10.63% |
| 2025-Q10/3 |
LoseXBIT / S&P -17.97% / -4.27% |
LoseXBIT / S&P XBIT unavailable / 4.98% |
LoseXBIT / S&P XBIT unavailable / 10.57% |
| 2024-Q40/3 |
LoseXBIT / S&P -48.90% / 2.41% |
LoseXBIT / S&P XBIT unavailable / 5.25% |
LoseXBIT / S&P XBIT unavailable / 6.15% |
| 2024-Q31/3 |
WinXBIT / S&P 50.39% / 5.89% |
LoseXBIT / S&P XBIT unavailable / 5.89% |
LoseXBIT / S&P XBIT unavailable / 6.11% |
| 2024-Q20/3 |
LoseXBIT / S&P -36.78% / 4.28% |
LoseXBIT / S&P XBIT unavailable / 5.38% |
LoseXBIT / S&P XBIT unavailable / 5.12% |
| 2024-Q11/3 |
WinXBIT / S&P 103.25% / 10.56% |
LoseXBIT / S&P XBIT unavailable / 5.71% |
LoseXBIT / S&P XBIT unavailable / 5.59% |
| 2023-Q40/3 |
LoseXBIT / S&P -2.91% / 11.69% |
LoseXBIT / S&P -100.00% / 6.81% |
LoseXBIT / S&P XBIT unavailable / 7.78% |
| 2023-Q30/3 |
LoseXBIT / S&P -30.64% / -3.27% |
LoseXBIT / S&P -96.35% / 7.52% |
LoseXBIT / S&P XBIT unavailable / -5.03% |
| 2023-Q21/3 |
WinXBIT / S&P 72.17% / 8.74% |
LoseXBIT / S&P -82.08% / 9.50% |
LoseXBIT / S&P XBIT unavailable / -8.57% |
| 2023-Q10/3 |
LoseXBIT / S&P -1.71% / 7.50% |
LoseXBIT / S&P -75.01% / 10.77% |
LoseXBIT / S&P XBIT unavailable / -15.69% |
| 2022-Q40/3 |
LoseXBIT / S&P -3.04% / 7.56% |
LoseXBIT / S&P -78.20% / 11.88% |
LoseXBIT / S&P XBIT unavailable / -17.99% |
| 2022-Q30/3 |
LoseXBIT / S&P -35.70% / -4.88% |
LoseXBIT / S&P -57.16% / 13.47% |
LoseXBIT / S&P XBIT unavailable / -1.41% |
| 2022-Q20/3 |
LoseXBIT / S&P -34.84% / -16.10% |
LoseXBIT / S&P -56.14% / 13.71% |
LoseXBIT / S&P XBIT unavailable / 11.04% |
| 2022-Q10/3 |
LoseXBIT / S&P -22.37% / -4.60% |
LoseXBIT / S&P -61.17% / 15.97% |
LoseXBIT / S&P XBIT unavailable / 42.23% |
| 2021-Q40/3 |
LoseXBIT / S&P -14.05% / 11.03% |
LoseXBIT / S&P -58.19% / 15.00% |
LoseXBIT / S&P XBIT unavailable / 96.40% |
| 2021-Q30/3 |
LoseXBIT / S&P -9.24% / 0.58% |
LoseXBIT / S&P -50.52% / 10.77% |
LoseXBIT / S&P XBIT unavailable / 69.42% |
| 2021-Q20/3 |
LoseXBIT / S&P -3.55% / 8.55% |
LoseXBIT / S&P -10.60% / 6.58% |
LoseXBIT / S&P XBIT unavailable / 51.81% |
| 2021-Q12/3 |
WinXBIT / S&P 9.71% / 6.17% |
WinXBIT / S&P 185.20% / -1.06% |
LoseXBIT / S&P XBIT unavailable / 7.39% |
| 2020-Q40/3 |
LoseXBIT / S&P -18.02% / 12.15% |
LoseXBIT / S&P XBIT unavailable / -3.72% |
LoseXBIT / S&P -102.49% / -33.42% |
| 2020-Q31/3 |
WinXBIT / S&P 39.24% / 8.93% |
LoseXBIT / S&P XBIT unavailable / -2.04% |
LoseXBIT / S&P XBIT unavailable / -27.10% |
| 2020-Q21/3 |
WinXBIT / S&P 29.10% / 20.54% |
LoseXBIT / S&P XBIT unavailable / -0.46% |
LoseXBIT / S&P XBIT unavailable / -27.11% |
| 2020-Q10/3 |
LoseXBIT / S&P -43.10% / -19.60% |
LoseXBIT / S&P XBIT unavailable / 3.47% |
LoseXBIT / S&P XBIT unavailable / -14.75% |
| 2019-Q41/3 |
WinXBIT / S&P 78.44% / 9.07% |
LoseXBIT / S&P XBIT unavailable / 5.36% |
LoseXBIT / S&P XBIT unavailable / 2.99% |
| 2019-Q31/3 |
WinXBIT / S&P 37.99% / 1.70% |
LoseXBIT / S&P XBIT unavailable / 5.02% |
LoseXBIT / S&P XBIT unavailable / 0.21% |
| 2019-Q20/3 |
LoseXBIT / S&P -31.22% / 4.30% |
LoseXBIT / S&P XBIT unavailable / 6.64% |
LoseXBIT / S&P XBIT unavailable / 8.65% |
| 2019-Q11/3 |
WinXBIT / S&P 116.93% / 13.65% |
LoseXBIT / S&P XBIT unavailable / 8.12% |
LoseXBIT / S&P XBIT unavailable / 14.29% |
| 2018-Q41/3 |
WinXBIT / S&P 59.75% / -13.52% |
LoseXBIT / S&P XBIT unavailable / 9.05% |
LoseXBIT / S&P XBIT unavailable / 18.23% |
| 2018-Q30/3 |
LoseXBIT / S&P -29.02% / 7.71% |
LoseXBIT / S&P XBIT unavailable / 10.21% |
LoseXBIT / S&P XBIT unavailable / 19.06% |
| 2018-Q20/3 |
LoseXBIT / S&P -16.26% / 3.43% |
LoseXBIT / S&P XBIT unavailable / 9.03% |
LoseXBIT / S&P XBIT unavailable / 14.46% |
| 2018-Q11/3 |
WinXBIT / S&P 35.79% / -0.76% |
LoseXBIT / S&P XBIT unavailable / 7.68% |
LoseXBIT / S&P XBIT unavailable / 12.46% |
| 2017-Q40/3 |
LoseXBIT / S&P -9.84% / 6.64% |
LoseXBIT / S&P XBIT unavailable / 7.03% |
LoseXBIT / S&P XBIT unavailable / 13.82% |
| 2017-Q30/3 |
LoseXBIT / S&P -7.02% / 4.48% |
LoseXBIT / S&P XBIT unavailable / 5.68% |
LoseXBIT / S&P XBIT unavailable / 17.57% |
| 2017-Q20/3 |
LoseXBIT / S&P -71.50% / 3.09% |
LoseXBIT / S&P XBIT unavailable / 4.83% |
LoseXBIT / S&P XBIT unavailable / 17.74% |
| 2017-Q11/3 |
WinXBIT / S&P 62.94% / 6.07% |
LoseXBIT / S&P XBIT unavailable / 3.67% |
LoseXBIT / S&P XBIT unavailable / 13.32% |
| 2016-Q40/3 |
LoseXBIT / S&P -24.81% / 3.82% |
LoseXBIT / S&P XBIT unavailable / 2.09% |
LoseXBIT / S&P XBIT unavailable / 7.05% |
| 2016-Q30/3 |
LoseXBIT / S&P -35.66% / 3.85% |
LoseXBIT / S&P XBIT unavailable / 0.20% |
LoseXBIT / S&P XBIT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | XBIT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -27.22% | 20.78% |
| Annualized return | -27.22% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | XBIT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.75% | 83.14% |
| Annualized return | -32.27% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | XBIT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -79.48% | 319.30% |
| Annualized return | -14.65% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |